Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Antibody Ascension.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Christel, Michael
- المصدر:
Pharmaceutical Executive. Sep2024, Vol. 44 Issue 9, p10-13. 4p.
- معلومة اضافية
- الموضوع:
- نبذة مختصرة :
The article presents the discussion on Genmab's ambitious vision for 2030, focusing on its transformation from an R&D-driven biotech to an integrated, end-to-end company with a commercial presence. Topics include its shift toward product ownership, expansion through partnerships and acquisitions; and its continued innovation in antibody drug development.
No Comments.